Myriad Genetics buy Raymond James
Start price
03.03.23
/
50%
€21.85
Target price
03.03.24
€25.45
Performance (%)
-7.55%
End price
04.03.24
€20.20
Summary
This prediction ended on 04.03.24 with a price of €20.20. With a performance of -7.55%, the BUY prediction for Myriad Genetics by Raymond_James closed slightly in the red. Raymond_James has a follow-up prediction for Myriad Genetics where he still thinks Myriad Genetics is a Buy. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Myriad Genetics | 3.109% | 3.109% | -44.336% | -80.865% |
| iShares Core DAX® | 4.852% | -2.747% | 13.097% | 46.787% |
| iShares Nasdaq 100 | 3.999% | -3.330% | 31.335% | 76.979% |
| iShares Nikkei 225® | 4.221% | -2.912% | 44.472% | 49.876% |
| iShares S&P 500 | 3.324% | -2.954% | 24.360% | 57.274% |
Comments by Raymond_James for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target raised by analysts at Raymond James from $25.00 to $27.00. They now have an "outperform" rating on the stock.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten